Back to search

Article

Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolism

2023-05-09

Abstract excerpt

<h4>ABSTRACT</h4> Tumor angiogenesis is a cancer hallmark, and its therapeutic inhibition has provided meaningful, albeit limited, clinical benefit. While anti-angiogenesis inhibitors deprive the tumor of oxygen and essential nutrients, cancer cells activate metabolic adaptations to diminish therapeutic response. Despite these adaptations, angiogenesis inhibition incurs extensive metabolic stress, prompting us to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
472e6f72-062c-5e29-a3e0-60f8697c5df6
DOI
10.1101/2023.05.07.539744
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Anaplerotic nutrient stress drives synergy of angiogenesis inhibitors with therapeutics targeting tumor metabolismDOI 10.1101/2023.05.07.539744
Select a neighboring publication to make it the new centre.